{"id":2441,"date":"2017-11-20T12:39:03","date_gmt":"2017-11-20T12:39:03","guid":{"rendered":"http:\/\/www.cardiolinkgroup.com\/entrevista-al-dr-abella-custodiol-htk-como-protector-miocardico-en-pacientes-neonatos\/"},"modified":"2017-12-05T12:50:59","modified_gmt":"2017-12-05T12:50:59","slug":"entrevista-al-dr-abella-custodiol-htk-como-protector-miocardico-en-pacientes-neonatos","status":"publish","type":"post","link":"https:\/\/www.cardiolinkgroup.com\/en\/entrevista-al-dr-abella-custodiol-htk-como-protector-miocardico-en-pacientes-neonatos\/","title":{"rendered":"Interview with Dr Abella: Custodiol HTK as a myocardial protector in neonatal patients"},"content":{"rendered":"

The week of November 20 was published in the\u00a0Diario Medico the interview conducted by Dr. Abella, Head of Children’s Cardiac Surgery Service in Vall d’Hebron Hospital of Barcelona. A study conducted in the same center that\u00a0shows, as a result, the efficacy of the solution Custodiol HTK in complex surgeries of congenital heart disease in neonates, which, the metabolic response of the myocardium offered a better result with Custodiol HTK. <\/span><\/p>\n

The objective of the study is to extend the results to different centers at the national level, in order to be able to elaborate a unified protocol applicable to all cardiac surgeries in children. If you want to know more about the ideal solution, both for cardioplegia and for organ preservation, do not hesitate to contact us.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

The week of November 20 was published in the\u00a0Diario Medico the interview conducted by Dr. Abella, Head of Children’s Cardiac Surgery Service in Vall d’Hebron Hospital of Barcelona. A study conducted in the same center that\u00a0shows, as a result, the efficacy of the solution Custodiol HTK in complex surgeries of congenital heart disease in neonates, […]<\/p>\n","protected":false},"author":2,"featured_media":2434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[124,90,57,55],"tags":[471,83,91,299,472,281,282,473,474,475,290],"class_list":["post-2441","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-organ_preservation","category-cardiolink-en","category-cardiac_surgery","category-general_surgery","tag-abella-en","tag-cardiolink-en","tag-cardiolink-group-en","tag-cardioplegia-en","tag-cardioplejia-en","tag-custodiol-en","tag-htk-en","tag-miocardio-en","tag-neonatos-en","tag-proteccion-miocardica-en","tag-vall-hebron-en"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t